SENS Senseonics upcoming catalyst!

SENS Senseonics is waiting for FDA`s approval for the 180-day version of its Eversense CGM system.

Eversense can generate as much as $200 million in sales by 2025.

HC Wainwright sees a 6usd price target for it.

And let`s not forget it`s a meme stock.





buyeversensefdafdaapprovalFundamental AnalysisTechnical IndicatorsSENSsenseonicssenseonicsholdingssignalsignalproviderTrend Analysis

Also on:

Disclaimer